The problems of the Stanford Financial Group-its chairman and two top executives have been accused of massive securities fraud-could complicate the sale of a health care software company represented by an Atlanta lawyer.
Emageon Inc., a client of David A. Stockton of Kilpatrick Stockton, was set to close the $62 million sale of itself on Feb. 11 when the buyer, Health Systems Solutions Inc., abruptly backed out. The company, called HSS, said funding from a member of the Stanford Financial network, Stanford International Bank Ltd., “will not be available” for the deal.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
